Stacey Brown

2.7k total citations
71 papers, 1.6k citations indexed

About

Stacey Brown is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Stacey Brown has authored 71 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 20 papers in Oncology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Stacey Brown's work include Hematopoietic Stem Cell Transplantation (40 papers), Acute Myeloid Leukemia Research (17 papers) and Acute Lymphoblastic Leukemia research (14 papers). Stacey Brown is often cited by papers focused on Hematopoietic Stem Cell Transplantation (40 papers), Acute Myeloid Leukemia Research (17 papers) and Acute Lymphoblastic Leukemia research (14 papers). Stacey Brown collaborates with scholars based in United States, Canada and United Kingdom. Stacey Brown's co-authors include Asad Bashey, Scott R. Solomon, Lawrence E. Morris, H. Kent Holland, Xu Zhang, Connie A. Sizemore, Melissa Sanacore, Karen Manion, Melhem Solh and Ronald Sobecks and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of the Acoustical Society of America.

In The Last Decade

Stacey Brown

67 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stacey Brown United States	19	1.2k	584	461	388	148	71	1.6k
C McGarigle United States	14	784 0.6×	493 0.8×	418 0.9×	190 0.5×	75 0.5×	16	1.3k
Ruta Brazauskas United States	18	870 0.7×	187 0.3×	372 0.8×	459 1.2×	69 0.5×	85	1.6k
S Rowley United States	11	925 0.8×	293 0.5×	432 0.9×	201 0.5×	37 0.3×	17	1.3k
Teresa Field United States	19	738 0.6×	207 0.4×	310 0.7×	228 0.6×	109 0.7×	69	1.1k
Jason Dehn United States	14	629 0.5×	344 0.6×	159 0.3×	213 0.5×	219 1.5×	28	874
Michael D. Amylon United States	22	765 0.6×	194 0.3×	299 0.6×	510 1.3×	43 0.3×	46	1.7k
Rachel B. Salit United States	16	717 0.6×	174 0.3×	251 0.5×	199 0.5×	52 0.4×	67	1.0k
GM Schmidt United States	18	942 0.8×	165 0.3×	447 1.0×	406 1.0×	48 0.3×	31	1.5k
S J Lee United States	12	322 0.3×	235 0.4×	224 0.5×	163 0.4×	39 0.3×	12	729
Lone Smidstrup Friis Denmark	16	744 0.6×	366 0.6×	281 0.6×	322 0.8×	5 0.0×	43	1.4k

Countries citing papers authored by Stacey Brown

Since Specialization

Citations

This map shows the geographic impact of Stacey Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacey Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacey Brown more than expected).

Fields of papers citing papers by Stacey Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacey Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacey Brown. The network helps show where Stacey Brown may publish in the future.

Co-authorship network of co-authors of Stacey Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Stacey Brown. A scholar is included among the top collaborators of Stacey Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacey Brown. Stacey Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bowles, Ben, et al.. (2025). 3D Printing with tuneable degradation: Thiol-ene and thiol-yne containing formulations for biomedical applications. International Journal of Pharmaceutics. 674. 125432–125432.

Solomon, Scott R., Melhem Solh, Lawrence E. Morris, et al.. (2023). Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplant. Blood Advances. 7(18). 5215–5224. 4 indexed citations

Solomon, Scott R., Stacey Brown, Katelin C Jackson, et al.. (2022). High-Dose Bendamustine, Etoposide, Cytarabine, and Melphalan (BeEAM) Conditioning Before Autologous Transplantation for Patients With Multiple Myeloma. Transplantation and Cellular Therapy. 28(8). 486.e1–486.e7. 4 indexed citations

Brown, Stacey, et al.. (2020). Creating a Comprehensive Approach to Exposing Underrepresented Pre-health Professions Students to Clinical Medicine and Health Research. Journal of the National Medical Association. 112(1). 36–43. 11 indexed citations

Solomon, Scott R., Connie A. Sizemore, Xu Zhang, et al.. (2018). Safety and efficacy of rituximab-based first line treatment of chronic GVHD. Bone Marrow Transplantation. 54(8). 1218–1226. 17 indexed citations

Solh, Melhem, Xu Zhang, Stacey Brown, et al.. (2016). Factors Predicting Graft-versus-Host Disease–Free, Relapse-Free Survival after Allogeneic Hematopoietic Cell Transplantation: Multivariable Analysis from a Single Center. Biology of Blood and Marrow Transplantation. 22(8). 1403–1409. 38 indexed citations

Zhang, Xu, Stacey Brown, Scott R. Solomon, et al.. (2016). T Cell–Replete HLA Haploidentical Donor Transplantation with Post-Transplant Cyclophosphamide Is an Effective Salvage for Patients Relapsing after an HLA-Matched Related or Matched Unrelated Donor Transplantation. Biology of Blood and Marrow Transplantation. 22(10). 1861–1866. 10 indexed citations

Solomon, Scott R., Connie A. Sizemore, Xu Zhang, et al.. (2016). Impact of Donor Type on Outcome after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia. Biology of Blood and Marrow Transplantation. 22(10). 1816–1822. 19 indexed citations

Solomon, Scott R., Connie A. Sizemore, Melissa Sanacore, et al.. (2015). Total Body Irradiation–Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors. Biology of Blood and Marrow Transplantation. 21(7). 1299–1307. 112 indexed citations

10.

Solomon, Scott R., Connie A. Sizemore, Xu Zhang, et al.. (2015). Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating Rituximab. Biology of Blood and Marrow Transplantation. 21(9). 1576–1582. 21 indexed citations

11.

Solomon, Scott R., Melissa Sanacore, Xu Zhang, et al.. (2014). Calcineurin Inhibitor–Free Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Brief-Course Sirolimus Following Reduced-Intensity Peripheral Blood Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(11). 1828–1834. 41 indexed citations

12.

Solomon, Scott R., Connie A. Sizemore, Stacey Brown, et al.. (2014). Preemptive DLI without withdrawal of immunosuppression to promote complete donor T-cell chimerism results in favorable outcomes for high-risk older recipients of alemtuzumab-containing reduced-intensity unrelated donor allogeneic transplant: a prospective phase II trial. Bone Marrow Transplantation. 49(5). 616–621. 33 indexed citations

13.

Bashey, Asad, Xu Zhang, Connie A. Sizemore, et al.. (2013). T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation. Journal of Clinical Oncology. 31(10). 1310–1316. 333 indexed citations

14.

Brown, Stacey, et al.. (2012). A Face to Meet the Faces: An Anthology of Contemporary Persona Poetry. Project Muse (Johns Hopkins University).

15.

Solomon, Scott R., Connie A. Sizemore, Melissa Sanacore, et al.. (2012). Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial. Biology of Blood and Marrow Transplantation. 18(12). 1859–1866. 207 indexed citations

16.

Sobecks, Ronald, Edward J. Ball, Medhat Askar, et al.. (2008). Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 41(8). 709–714. 13 indexed citations

17.

Smith, Stephen D., Brian J. Bolwell, Lisa Rybicki, et al.. (2007). Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen. Bone Marrow Transplantation. 40(3). 239–243. 41 indexed citations

18.

Rybicki, Lisa, Brian J. Bolwell, Sachin G. Thakkar, et al.. (2007). Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma. Bone Marrow Transplantation. 40(10). 973–978. 18 indexed citations

19.

Blum, William, Brian J. Bolwell, Gary Phillips, et al.. (2006). High Disease Burden Is Associated with Poor Outcomes for Patients with Acute Myeloid Leukemia Not in Remission Who Undergo Unrelated Donor Cell Transplantation. Biology of Blood and Marrow Transplantation. 12(1). 61–67. 16 indexed citations

20.

Bolwell, Brian J., Brad Pohlman, Ronald Sobecks, et al.. (2003). Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant. Bone Marrow Transplantation. 33(4). 419–423. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact